GeneDx Holdings Corp. Investors with Significant Losses Can Lead Securities Fraud Lawsuit
Investors who have incurred losses exceeding $100,000 in GeneDx Holdings Corp. securities have the opportunity to lead a securities fraud lawsuit. The deadline to apply is August 3, 2026.
Rosen Law Firm is notifying purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock who have suffered losses of $100,000 or more that they may be able to lead a securities fraud class action lawsuit.
The lawsuit alleges securities fraud against investors who purchased the company's stock between April 16, 2025, and May 4, 2026. The court has set an August 3, 2026, deadline for eligible investors to seek appointment as lead plaintiff.
The firm states that investors with the largest financial losses are typically prioritized to serve as lead plaintiff. This role may offer additional opportunities for recovery.
Interested investors are encouraged to contact Rosen Law Firm to learn more about the lawsuit and their potential rights.